Global Care Capital Inc.

Recent News

  • Global Care Capital Announces Amendment to Investor Agreement

    Vancouver, British Columbia--(Newsfile Corp. - October 20, 2022) - Global Care Capital Inc. (CSE: HLTH) (FSE: L6V2) (the "Company" or "Global Care") a global investment company which engages in early-stage investment opportunities in private and public companies, announces that it has entered into an amendment agreement dated October 19, 2022 (the "Amending Agreement") amending certain terms of the convertible securities purchase agreement dated February 25, 2022 (the "Agreement") with Mirabel Capital, Ltd. (the "Investor" or "Mirabel"), the details of which are...

    2022-10-20 8:30 AM EDT
  • Global Care Capital Announces Change of Directors

    Vancouver, British Columbia--(Newsfile Corp. - September 28, 2022) - Global Care Capital Inc. (CSE: HLTH) (FSE: L6V2) (the "Company" or "Global Care") announces the appointment of Ho Hung Ricky Chung to the Board of Directors, taking the place of Alexander Somjen, who has resigned. Mr. Chung graduated from BCIT in Electrical and Electronic Engineering in 1979, and also obtained a bachelor's degree in Electrical and Electronic Engineering from the University of British Columbia. Mr. Chung was employed...

    2022-09-28 4:39 PM EDT
  • Global Care Capital Announces Conversion of Convertible Securities

    Vancouver, British Columbia--(Newsfile Corp. - August 16, 2022) - Global Care Capital Inc. (CSE: HLTH) (FSE: L6V2) (the "Company" or "Global Care"), a global investment company which engages in early-stage investment opportunities in private and public companies, announces, further to the Company's news release dated February 25, 2022, that the Company has received conversion notices (the "Conversion Notices") from Mirabel Capital, Ltd. (the "Investor"), an institutional investor, to convert a total amount of US$290,000 pursuant to the terms and conditions...

    2022-08-16 8:41 PM EDT
  • Resinco Capital Partners Funds Stem Cell Project at Oxford University

    Vancouver, British Columbia--(Newsfile Corp. - March 15, 2019) - Resinco Capital Partners Inc. (CSE: RIN) (OTC Pink: RSCZF) (FSE: L6V1) (the "Company" or "Resinco"), a global investment company which specializes in providing early-stage financing to private and public companies, is pleased to announce funding for a project at the University of Oxford in the laboratory of Professor Jagdeep Nanchahal.Through the Company's wholly owned subsidiary ReFormation Pharmaceuticals Corp. ("ReFormation") and in partnership with 180 Therapeutics LP, a clinical stage biopharmaceutical company...

    2019-03-15 4:47 PM EDT
  • Resinco Capital Partners Announces the Appointment of Sir Marc Feldmann to Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2019) - Resinco Capital Partners Inc. (CSE: RIN) (OTC Pink: RSCZF) (FSE: L6V1) (the "Company" or "Resinco") is pleased to announce that the Company has appointed pioneer and trailblazer of modern immunology, Sir Marc Feldmann, to its Advisory Board after fully acquiring his company, ReFormation Pharmaceuticals Corp, a medical cannabis company developing innovative, first-in-class therapies to repair vital organs and stem cells by combining cannabinoids and an endogenous trigger of repair.Sir Marc Feldmann,...

    2019-02-06 12:00 AM EST
  • Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp

    Vancouver, British Columbia--(Newsfile Corp. - January 16, 2019) - Resinco Capital Partners Inc. (CSE: RIN) (OTC Pink: RSCZF) (FSE: L6V1) (the "Company" or "Resinco") is pleased to announce that the Company has entered into a definitive agreement to acquire the remaining 51% of ReFormation Pharmaceuticals Corp, a medical cannabis company developing innovative, first-in-class therapies to repair vital organs and stem cells by combining cannabinoids and an endogenous trigger of repair. Resinco previously acquired 49% of ReFormation's outstanding shares on October...

    2019-01-16 12:02 AM EST